Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -450.54% is 281% below its 5-year average of -118.23%, near the low end of its 5-year range (-504.44%–-30.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.81% below its 12-month average of -251.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -450.54%.
RETURN ON EQUITY (ROE)
-450.54%
RETURN ON EQUITY (ROE) AVG TTM
-251.97%
RETURN ON EQUITY (ROE) AVG 3Y
-263.42%
RETURN ON EQUITY (ROE) AVG 5Y
-118.23%
RETURN ON EQUITY (ROE) AVG 10Y
-154.16%
RETURN ON EQUITY (ROE) AVG 15Y
-95.73%
RETURN ON EQUITY (ROE) AVG 20Y
-63.55%
CURRENT VS TTM AVG
-78.81%
CURRENT VS 3Y AVG
-71.04%
CURRENT VS 5Y AVG
-281.07%
CURRENT VS 10Y AVG
-192.26%
CURRENT VS 15Y AVG
-370.62%
CURRENT VS 20Y AVG
-608.96%
SECTOR MEDIAN · HEALTHCARE
-38.53%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-1069.33%
vs the sector median at left
Curis, Inc.
Market Cap
$1.46M
Return on Equity (ROE)
-450.54%
TTM Avg
-251.97%
3Y Avg
-263.42%
5Y Avg
-118.23%
Market Cap
$1.46M
Return on Equity (ROE)
-169.64%
TTM Avg
97.92%
3Y Avg
65.28%
5Y Avg
65.28%
Market Cap
$1.45M
Return on Equity (ROE)
-80.57%
TTM Avg
-96.07%
3Y Avg
-115.92%
5Y Avg
51.19%
Market Cap
$1.45M
Return on Equity (ROE)
-32.05%
TTM Avg
-197.10%
3Y Avg
-44.98%
5Y Avg
-69.38%
Market Cap
$1.38M
Return on Equity (ROE)
-253.57%
TTM Avg
334.28%
3Y Avg
134.39%
5Y Avg
95.16%
Market Cap
$1.31M
Return on Equity (ROE)
-111.51%
TTM Avg
-753.43%
3Y Avg
-507.39%
5Y Avg
-356.28%
Market Cap
$1.19M
Return on Equity (ROE)
N/A
TTM Avg
558.67%
3Y Avg
54.46%
5Y Avg
-8.27%
Market Cap
$1.16M
Return on Equity (ROE)
N/A
TTM Avg
206.72%
3Y Avg
141.32%
5Y Avg
115.74%
Market Cap
$1.11M
Return on Equity (ROE)
-11.85%
TTM Avg
-6.20%
3Y Avg
47.36%
5Y Avg
47.36%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curis, Inc. (CRIS) | $1.46M | -450.54% | -251.97% | -263.42% | -118.23% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | -169.64% | 97.92% | 65.28% | 65.28% |
| PMGC Holdings Inc. (ELAB)vs › | $1.45M | -80.57% | -96.07% | -115.92% | 51.19% |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | -32.05% | -197.10% | -44.98% | -69.38% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | -253.57% | 334.28% | 134.39% | 95.16% |
| Genprex, Inc. (GNPX)vs › | $1.31M | -111.51% | -753.43% | -507.39% | -356.28% |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | N/A | 558.67% | 54.46% | -8.27% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | N/A | 206.72% | 141.32% | 115.74% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | -11.85% | -6.20% | 47.36% | 47.36% |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | -57.87% | -222.45% | -164.72% | -135.78% |
ROE
-450.5%
ROA
-111.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -450.54% |
| 2026-03-31 | -166.56% |
| 2025-12-31 | -138.81% |
| 2024-03-31 | -504.44% |
| 2023-12-31 | -241.04% |
| 2023-09-30 | -158.93% |
| 2023-06-30 | -183.58% |
| 2023-03-31 | -142.45% |
| 2022-12-31 | -121.74% |
| 2022-09-30 | -105.77% |
| 2022-06-30 | -91.42% |
| 2022-03-31 | -67.94% |
| 2021-12-31 | -50.09% |
| 2021-09-30 | -38.22% |
| 2021-06-30 | -30.46% |
| 2021-03-31 | -24.71% |
| 2020-12-31 | -22.89% |
| 2018-06-30 | -603.32% |
| 2018-03-31 | -334.02% |
| 2017-12-31 | -222.22% |
| 2017-09-30 | -185.98% |
| 2017-06-30 | -753.27% |
| 2017-03-31 | -310.62% |
| 2016-12-31 | -206.42% |
| 2016-09-30 | -165.14% |
| 2016-06-30 | -86.03% |
| 2016-03-31 | -65.38% |
| 2015-12-31 | -91.43% |
| 2015-09-30 | -67.39% |
| 2015-06-30 | -63.60% |
| 2015-03-31 | -51.38% |
| 2014-12-31 | -62.88% |
| 2014-09-30 | -49.75% |
| 2014-06-30 | -34.32% |
| 2014-03-31 | -31.88% |
| 2013-12-31 | -27.28% |
| 2013-09-30 | -49.30% |
| 2013-06-30 | -67.20% |
| 2013-03-31 | -78.04% |
| 2012-12-31 | -47.91% |
| 2012-09-30 | 4.41% |
| 2012-06-30 | 2.54% |
| 2012-03-31 | -1.75% |
| 2011-12-31 | -24.72% |
| 2011-09-30 | -66.43% |
| 2011-06-30 | -52.14% |
| 2011-03-31 | -39.54% |
| 2010-12-31 | -9.74% |
| 2010-09-30 | -3.03% |
| 2010-06-30 | -7.87% |
| 2010-03-31 | -11.51% |
| 2009-12-31 | -29.72% |
| 2009-09-30 | -26.93% |
| 2009-06-30 | -27.77% |
| 2009-03-31 | -19.45% |
| 2008-12-31 | -32.57% |
| 2008-09-30 | -14.64% |
| 2008-06-30 | -11.26% |
| 2008-03-31 | -15.49% |
| 2007-12-31 | -14.87% |
| 2007-09-30 | -25.36% |
| 2007-06-30 | -27.69% |
| 2007-03-31 | -24.98% |
| 2006-12-31 | -24.60% |
| 2006-09-30 | -32.08% |
| 2006-06-30 | -37.67% |
| 2006-03-31 | -36.94% |
| 2005-12-31 | -39.09% |
| 2005-09-30 | -36.31% |
| 2005-06-30 | -35.79% |
| 2005-03-31 | -31.80% |
| 2004-12-31 | -28.43% |
| 2004-09-30 | -62.04% |
| 2004-06-30 | -31.58% |
| 2004-03-31 | -30.20% |
| 2003-12-31 | -29.91% |
| 2003-09-30 | 17.69% |
| 2003-06-30 | -9.91% |
